Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1990 1
1991 1
1992 4
1993 3
1996 1
1998 3
1999 7
2000 2
2001 5
2002 4
2003 5
2004 3
2005 1
2006 2
2008 1
2009 2
2010 1
2011 2
2012 2
2013 2
2014 2
2015 5
2016 2
2017 4
2018 11
2019 7
2020 5
2021 7
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

92 results
Results by year
Filters applied: . Clear all
Page 1
Special issue: Is BPA an ED?
Beausoleil C, Pasquier E, Rousselle C, Michel C. Beausoleil C, et al. Among authors: rousselle c. Mol Cell Endocrinol. 2018 Nov 5;475:1-3. doi: 10.1016/j.mce.2018.06.008. Mol Cell Endocrinol. 2018. PMID: 30149972 No abstract available.
[Neuropsychological consequences of craniosynostosis: Non-syndromic scaphocephaly].
Verlut I, Mottolese C, Szathmari A, Banvillet E, Poncet A, Blache A, Rousselle C, Gleizal A, Paulus C, Di Rocco F. Verlut I, et al. Among authors: rousselle c. Neurochirurgie. 2019 Nov;65(5):330-336. doi: 10.1016/j.neuchi.2019.09.018. Epub 2019 Oct 1. Neurochirurgie. 2019. PMID: 31585152 Review. French.
Concerns related to ED-mediated effects of Bisphenol A and their regulatory consideration.
ANSES's Working Group on « Endocrine disruptors », ANSES's Expert Committee on « Chemicals covered by the REACh and CLP Regulations », Pouzaud F, Thierry-Mieg M, Burga K, Vérines-Jouin L, Fiore K, Beausoleil C, Michel C, Rousselle C, Pasquier E. ANSES's Working Group on « Endocrine disruptors », ANSES's Expert Committee on « Chemicals covered by the REACh and CLP Regulations », et al. Among authors: rousselle c. Mol Cell Endocrinol. 2018 Nov 5;475:92-106. doi: 10.1016/j.mce.2018.02.002. Epub 2018 Feb 8. Mol Cell Endocrinol. 2018. PMID: 29428396 Review.
Advancing human health risk assessment.
Lanzoni A, Castoldi AF, Kass GE, Terron A, De Seze G, Bal-Price A, Bois FY, Delclos KB, Doerge DR, Fritsche E, Halldorsson T, Kolossa-Gehring M, Hougaard Bennekou S, Koning F, Lampen A, Leist M, Mantus E, Rousselle C, Siegrist M, Steinberg P, Tritscher A, Van de Water B, Vineis P, Walker N, Wallace H, Whelan M, Younes M. Lanzoni A, et al. Among authors: rousselle c. EFSA J. 2019 Jul 8;17(Suppl 1):e170712. doi: 10.2903/j.efsa.2019.e170712. eCollection 2019 Jul. EFSA J. 2019. PMID: 32626449 Free PMC article.
Regulatory identification of BPA as an endocrine disruptor: Context and methodology.
Beausoleil C, Emond C, Cravedi JP, Antignac JP, Applanat M, Appenzeller BR, Beaudouin R, Belzunces LP, Canivenc-Lavier MC, Chevalier N, Chevrier C, Elefant E, Eustache F, Habert R, Kolf-Clauw M, Le Magueresse-Battistoni B, Mhaouty-Kodja S, Minier C, Multigner L, Schroeder H, Thonneau P, Viguié C, Pouzaud F, Ormsby JN, Rousselle C, Verines-Jouin L, Pasquier E, Michel C. Beausoleil C, et al. Among authors: rousselle c. Mol Cell Endocrinol. 2018 Nov 5;475:4-9. doi: 10.1016/j.mce.2018.02.001. Epub 2018 Feb 6. Mol Cell Endocrinol. 2018. PMID: 29426018 Free article. Review.
The SCCS scientific advice on the safety of nanomaterials in cosmetics.
SCCS members. Electronic address: SANTE-C2-SCCS@ec.europa.eu, Bernauer U, Bodin L, Chaudhry Q, Coenraads PJ, Dusinska M, Gaffet E, Panteri E, Rogiers V, Rousselle C, Stepnik M, Vanhaecke T, Wijnhoven S; Other experts, von Goetz N, de Jong WH. SCCS members. Electronic address: SANTE-C2-SCCS@ec.europa.eu, et al. Among authors: rousselle c. Regul Toxicol Pharmacol. 2021 Nov;126:105046. doi: 10.1016/j.yrtph.2021.105046. Epub 2021 Sep 22. Regul Toxicol Pharmacol. 2021. PMID: 34560169
Vector-mediated drug delivery to the brain.
Temsamani J, Rousselle C, Rees AR, Scherrmann JM. Temsamani J, et al. Among authors: rousselle c. Expert Opin Biol Ther. 2001 Sep;1(5):773-82. doi: 10.1517/14712598.1.5.773. Expert Opin Biol Ther. 2001. PMID: 11728213 Review.
Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future.
Louro H, Heinälä M, Bessems J, Buekers J, Vermeire T, Woutersen M, van Engelen J, Borges T, Rousselle C, Ougier E, Alvito P, Martins C, Assunção R, Silva MJ, Pronk A, Schaddelee-Scholten B, Del Carmen Gonzalez M, de Alba M, Castaño A, Viegas S, Humar-Juric T, Kononenko L, Lampen A, Vinggaard AM, Schoeters G, Kolossa-Gehring M, Santonen T. Louro H, et al. Among authors: rousselle c. Int J Hyg Environ Health. 2019 Jun;222(5):727-737. doi: 10.1016/j.ijheh.2019.05.009. Epub 2019 Jun 5. Int J Hyg Environ Health. 2019. PMID: 31176761 Free article. Review.
92 results